Social Media Sidebar

Announcement

Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

People say we're running out of energy. That's only true if we stick with these old 19th century technologies. We are awash in energy from sunlight.

 

Ray Kurzweil

 

MS breakthrough: Replacing diseased immune system halts progression and allows repair

RATE THIS! +51
Posted in Science on 12th Jun, 2016 05:56 PM by AlexMuller

A trial shows that an intensive procedure that wipes out the immune system and then regenerates a new one using blood stem cells can eliminate signs of damaging brain inflammation in people with early, aggressive multiple sclerosis and facilitate lasting recovery. 

 
Led by Dr. Harold Atkins and Dr. Mark S. Freedman of The Ottawa Hospital and the University of Ottawa, the trial included 24 participants who were followed for up to 13 years. The $6.47 million trial was funded by the MS Society of Canada and its affiliated Multiple Sclerosis Scientific Research Foundation. The research was also supported by The Ottawa Hospital Foundation, The Ottawa Hospital Department of Medicine and Canadian Blood Services.
 
“Our trial is the first to show the complete, long-term suppression of all inflammatory activity in people with MS,” said Dr. Atkins, a stem cell transplant physician and scientist at The Ottawa Hospital, and associate professor at the University of Ottawa. “This is very exciting. However, it is important to note that this therapy can have serious side effects and risks, and would only be appropriate for a small proportion of people with very active MS. People with MS who have had significant disability for a long time would likely not benefit.”
 
“This procedure should be considered as a treatment option for people with early, aggressive MS,” said Dr. Freedman, a neurologist and senior scientist at The Ottawa Hospital and professor at the University of Ottawa. “Although this trial was relatively small, it was intensive, with the longest prospective follow-up of any such treatment group to date, and that is what makes the results so convincing. However, this is a very complex procedure that should only be performed at very specialized centres with expertise in both the management of MS patients and blood stem cell transplantation.”
 
MS affects approximately 2.3 million people around the world, causing symptoms that range from blurred vision to extreme fatigue to partial or complete paralysis. It occurs when the immune system – which normally protects against foreign disease-causing organisms – mistakenly attacks the body’s own central nervous system, which includes the brain, spinal cord and optic nerve. Early in the disease, people often experience temporary episodes of worsening symptoms accompanied by active inflammation in the brain (called relapses), whereas later on, disease progression is inevitable. 
 
The trial evaluated a treatment called immunoablation and autologous hematopoietic stem cell transplantation (IAHSCT). The procedure begins by giving a person medication to coax their hematopoietic stem cells to migrate from their bone marrow into their blood. These stem cells are then collected from the blood, purified and frozen. Then, high doses of chemotherapy drugs are used to eliminate the person’s diseased immune system. The stem cells are then transplanted back into the same person, so that they can give rise to a new immune system that has no “memory” of the previous pattern of attacking the central nervous system. 
 
The trial included 24 participants with aggressive, relapsing MS. They were followed for anywhere between four and 13 years after treatment (with a median post-treatment follow up of 6.7 years). 
 
After the treatment:
 
Not a single participant experienced a clinical relapse (zero relapses in 179 patient-years), whereas before treatment, the participants experienced an average of 1.2 relapses per year (167 relapses in 146 patient-years).
 
Not a single new active inflammatory lesion could be detected in the brains of any of the participants (zero lesions on 327 MRI scans) whereas before the treatment, participants had 188 lesions on 48 scans. 
 
Not a single participant required MS-specific drugs to control their disease.
 
70 percent of participants experienced a complete stop in disease progression.

Tags: healthmedicineimmune systemmultiple sclerosisresearchclinical trial

Read original article » Back to category

Comments

Author: Guest
Posted: 2016-06-13
+1
Hopefully, further research and clinical trials will confirm that this strategy of regenerating immune system is effective for multiple sclerosis patients
1 Replies
Author: Guest
Posted: 2016-06-13
+0
The data look strong and very encouraging, this should be very important step forward Reply
Reply


 

Recent headlines

  • Posted in Medicine on 2017-08-21 19:26:00
    Darmiyan’s software detects early stages of Alzheimer’s..read more
    Posted in Business on 2017-08-21 19:20:53
    Google needs to pay Apple a fortune to remain the default.....read more
    Posted in Medicine on 2017-08-21 19:15:22
    Artificial Intelligence beats doctors at diagnosing.....read more
    Posted in Science on 2017-08-20 16:55:58
    Computer Approaches Human Skill for First Time in Mapping.....read more
    Posted in Science on 2017-08-20 16:51:23
    Researchers use polystyrene to make next-generation of.....read more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in about.....read more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for commercial.....read more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 Downloads..read more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into new.....read more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs,.....read more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for commercial.....read more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short Sighted..read more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, but.....read more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in about.....read more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target mitochondria..read more

Recent Blog Posts

  • Posted by AlexMuller
    Scientists probe Neptune's depths to reveal secrets of icy.....read more
    Posted by AlexMuller
    New terahertz imaging approach could speed up skin cancer.....read more
    Posted by AlexMuller
    Rebutting the claim that antidepressants do not work..read more
    Posted by AlexMuller
    Artificial neural networks decode brain activity during.....read more
    Posted by AlexMuller
    Four Earth-sized planets detected orbiting the nearest.....read more

Login to your Account

Login to your PlanetTech Account here

Username:
Password:
Remember me
or

Create a New Account

You just need username and password

The following errors occured:
Username:
Email:
Password:
Verify password:
Remember me